Feasibility of Weekly Electronic Health Record–Embedded Patient-Reported Outcomes for Patients Starting Oral Cancer–Directed Therapy-Reference-Cited by-同舟云学术

Feasibility of Weekly Electronic Health Record–Embedded Patient-Reported Outcomes for Patients Starting Oral Cancer–Directed Therapy

Published:2023-09 Issue:7 Volume: Page:
ISSN:2473-4276
Container-title:JCO Clinical Cancer Informatics
language:en
Short-container-title:JCO Clinical Cancer Informatics

Author:

Doolin Jim W.¹^ORCID,Haakenstad Ellana K.¹,Neville Bridget A.²,Lipsitz Stu R.²^ORCID,Zhang Sunyi¹,Cleveland Jessica L.F.¹^ORCID,Hiruy Semegne¹^ORCID,Hassett Michael J.¹^ORCID,Revette Anna¹,Schrag Deborah³^ORCID,Basch Ethan⁴^ORCID,McCleary Nadine J.⁵^ORCID

Affiliation:

1. Department of Quality and Patient Safety, Dana-Farber Cancer Institute, Boston, MA

2. Center for Surgery and Public Health, Brigham and Womens' Hospital, Boston, MA

3. Memorial Sloan Kettering Cancer Center, New York, NY

4. University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC

5. Department of Medical Oncology, Gastrointestinal Oncology, Dana-Farber Cancer Institute, Boston, MA

Abstract

DFCI feasibility study shows patients on oral anticancer Rx's use EHR-embedded ePROs, but there is room to improve.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

General Medicine

Link

https://ascopubs.org/doi/pdfdirect/10.1200/CCI.23.00043

Reference42 articles.

1. Oral chemotherapy safety practices at US cancer centres: questionnaire survey

2. Real-world Use of and Spending on New Oral Targeted Cancer Drugs in the US, 2011-2018

3. Nonadherence to Imatinib adversely affects event free survival in chronic phase chronic myeloid leukemia

4. Patient Experiences With Oral Chemotherapy: Adherence, Symptoms, and Quality of Life

5. Persistence, adherence, and toxicity with oral CMF in older women with early-stage breast cancer (Adherence Companion Study 60104 for CALGB 49907)